AEMD
NASD Aethlon Medical, Inc.$6.51 ↓ -0.13 (-1.89%) Trading Down from the previous close of $6.63, $0.19 below the day’s high of $6.69
- YTD change
- -53.03%
- vs 20-day SMA
- +50.35%
- vs 200-day SMA
- -24.45%
Price ranges
Price & Performance
+4.51 (+212.74%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $49,960.00
- AEMD is down 53% since the beginning of the year
- AEMD is down 84% over the past 12 months
- AEMD is up 257% over the past 1 month
- 5% of all AEMD investors are betting against AEMD
AEMD reads neutral: price sits above one of the two key moving averages, the 12-month move is +729.5%.
- Previous minute
- +$0.00
- Last hour
- -$0.02
- Last 5 days
- -3.91%
- vs 8-day SMA
- -0.57%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.